UnitedHealth Group Incorporated (NYSE:UNH) was the recipient of unusually large options trading on Wednesday. Stock traders purchased 19,286 call options on the company. This represents an increase of 675% compared to the average volume of 2,488 call options.
In other news, Director Kenneth Irwin Shine sold 838 shares of the firm’s stock in a transaction on Wednesday, April 19th. The stock was sold at an average price of $169.12, for a total value of $141,722.56. Following the transaction, the director now directly owns 28,528 shares in the company, valued at approximately $4,824,655.36. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director William C. Ballard, Jr. sold 5,000 shares of the firm’s stock in a transaction on Wednesday, June 7th. The stock was sold at an average price of $182.64, for a total value of $913,200.00. Following the completion of the transaction, the director now owns 75,735 shares in the company, valued at $13,832,240.40. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 30,378 shares of company stock worth $5,285,052. Company insiders own 0.89% of the company’s stock.
A number of hedge funds have recently added to or reduced their stakes in UNH. Osborn Williams & Donohoe LLC increased its stake in shares of UnitedHealth Group by 8.1% in the fourth quarter. Osborn Williams & Donohoe LLC now owns 9,716 shares of the healthcare conglomerate’s stock worth $1,555,000 after buying an additional 732 shares in the last quarter. Barometer Capital Management Inc. increased its stake in shares of UnitedHealth Group by 9.2% in the fourth quarter. Barometer Capital Management Inc. now owns 111,200 shares of the healthcare conglomerate’s stock worth $17,796,000 after buying an additional 9,400 shares in the last quarter. NN Investment Partners Holdings N.V. increased its stake in shares of UnitedHealth Group by 9.8% in the fourth quarter. NN Investment Partners Holdings N.V. now owns 1,124,920 shares of the healthcare conglomerate’s stock worth $180,032,000 after buying an additional 100,295 shares in the last quarter. Lederer & Associates Investment Counsel CA purchased a new stake in shares of UnitedHealth Group during the fourth quarter worth about $304,000. Finally, First Heartland Consultants Inc. increased its stake in shares of UnitedHealth Group by 6.4% in the third quarter. First Heartland Consultants Inc. now owns 1,889 shares of the healthcare conglomerate’s stock worth $264,000 after buying an additional 114 shares in the last quarter. Institutional investors own 86.69% of the company’s stock.
UnitedHealth Group (UNH) opened at 181.63 on Friday. UnitedHealth Group has a 52-week low of $132.39 and a 52-week high of $183.76. The stock has a market cap of $175.03 billion, a price-to-earnings ratio of 23.25 and a beta of 0.65. The company has a 50-day moving average price of $176.17 and a 200 day moving average price of $166.97.
UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, April 18th. The healthcare conglomerate reported $2.37 EPS for the quarter, beating the Zacks’ consensus estimate of $2.17 by $0.20. The company had revenue of $48.72 billion during the quarter, compared to the consensus estimate of $48.21 billion. UnitedHealth Group had a net margin of 4.13% and a return on equity of 21.42%. UnitedHealth Group’s quarterly revenue was up 9.4% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.81 EPS. On average, analysts expect that UnitedHealth Group will post $9.80 earnings per share for the current year.
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 27th. Shareholders of record on Monday, June 19th will be issued a $0.75 dividend. This is an increase from UnitedHealth Group’s previous quarterly dividend of $0.63. The ex-dividend date of this dividend is Thursday, June 15th. This represents a $3.00 dividend on an annualized basis and a yield of 1.65%. UnitedHealth Group’s dividend payout ratio is presently 31.13%.
A number of equities analysts have recently issued reports on the company. BidaskClub upgraded UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Friday, June 9th. Leerink Swann restated an “outperform” rating on shares of UnitedHealth Group in a research note on Friday, June 9th. Morgan Stanley assumed coverage on UnitedHealth Group in a research note on Tuesday, June 6th. They issued an “overweight” rating and a $202.00 price target on the stock. Zacks Investment Research upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $201.00 price target on the stock in a research note on Wednesday, June 7th. Finally, Vetr downgraded UnitedHealth Group from a “buy” rating to a “hold” rating and set a $186.50 price target on the stock. in a research note on Monday, June 5th. One investment analyst has rated the stock with a hold rating and twenty-five have issued a buy rating to the stock. The stock has a consensus rating of “Buy” and a consensus price target of $184.23.
ILLEGAL ACTIVITY WARNING: This piece of content was originally posted by sleekmoney and is owned by of sleekmoney. If you are accessing this piece of content on another domain, it was illegally copied and republished in violation of U.S. and international trademark & copyright law. The legal version of this piece of content can be viewed at https://sleekmoney.com/investors-purchase-high-volume-of-call-options-on-unitedhealth-group-unh/1916897.html.
About UnitedHealth Group
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
This story was originally published by sleekmoney (https://sleekmoney.com) and is the sole property of sleekmoney. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at https://sleekmoney.com/investors-purchase-high-volume-of-call-options-on-unitedhealth-group-unh/1916897.html
Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.